Download Free Sample Report

Transmucosal Drug Delivery Systems Market, Global Outlook and Forecast 2022-2028

Transmucosal Drug Delivery Systems Market, Global Outlook and Forecast 2022-2028

  • Published on : 23 June 2022
  • Pages :65
  • Report Code:SMR-7161836

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first pass metabolism.
This report contains market size and forecasts of Transmucosal Drug Delivery Systems in Global, including the following market information:

  • Global Transmucosal Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)

The global Transmucosal Drug Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Drug Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transmucosal Drug Delivery Systems include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, Acrux Limited, ALZA Corporation, DURECT Corporation and Generex Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transmucosal Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transmucosal Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Transmucosal Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)

  • Oral Drug Delivery
  • Nasal Drug Delivery
  • Rectal Drug Delivery
  • Other

Global Transmucosal Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Transmucosal Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)

  • Hospitals
  • Clinics
  • Others

Global Transmucosal Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Transmucosal Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

  • Key companies Transmucosal Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Transmucosal Drug Delivery Systems revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • 3M
  • Antares Pharma
  • Aveva Drug Delivery Systems
  • Corium International
  • Acrux Limited
  • ALZA Corporation
  • DURECT Corporation
  • Generex Biotechnology